Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?  

作　　者：Dimitrios S Politis Konstantinos H Katsanos Konstantinos Papamichael Maria Saridi Eleni Albani Dimitrios K Christodoulou 

机构地区：[1]Department of Gastroenterology,University Hospital of Ioannina,Faculty of Medicine,School of Health Sciences,University of Ioannina,Ioannina 45110,Greece [2]Center for Inflammatory Bowel Diseases,Division of Gastroenterology,Beth-Israel Deaconess Medical Center,Harvard Medical School,Boston,MA 02215,United States [3]General Hospital of Corinth,Department of Social and Educational Policy,University of Peloponnese,Corinth 20100,Greece [4]Department of Nursing,TEI of Western Greece,Patra 26334,Greece

出　　处：《World Journal of Gastrointestinal Endoscopy》2019年第6期424-426,共3页世界胃肠内镜杂志（英文版）（电子版）

摘　　要：Patients with inflammatory bowel diseases (IBD) represent heterogeneous groups with different characteristics and different clinical course. A great deal of effort is made to discover proxies for more severe disease needing more intense treatment and early intervention to gain the maximum therapeutic benefit. Endoscopy remains an invaluable method in assessment of patients with IBD. Pseudopolyps are often encountered during endoscopy and, although they are a well described entity, their presence is of unclear importance. In one of our recent studies and in conjunction with one study with a large cohort of patients with IBD and pseudopolyps, patients with pseudopolyps were found to face a higher inflammatory burden in terms of receiving more intense biological treatment. This letter comes as a comment and proposition regarding the concept of reevaluation of pseudopolyps as a promising marker in IBD scores.Patients with inflammatory bowel diseases(IBD) represent heterogeneous groups with different characteristics and different clinical course. A great deal of effort is made to discover proxies for more severe disease needing more intense treatment and early intervention to gain the maximum therapeutic benefit. Endoscopy remains an invaluable method in assessment of patients with IBD. Pseudopolyps are often encountered during endoscopy and, although they are a well described entity, their presence is of unclear importance. In one of our recent studies and in conjunction with one study with a large cohort of patients with IBD and pseudopolyps, patients with pseudopolyps were found to face a higher inflammatory burden in terms of receiving more intense biological treatment.This letter comes as a comment and proposition regarding the concept of reevaluation of pseudopolyps as a promising marker in IBD scores.

关 键 词：Pseudopolyps INFLAMMATORY BOWEL DISEASES Treatment ESCALATION ENDOSCOPIC SCORES 

分 类 号：R[医药卫生]